In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody

被引：0
|
作者：
Ning Ding
Kohei Sano
Kengo Kanazaki
Manami Ohashi
Jun Deguchi
Yuko Kanada
Masahiro Ono
Hideo Saji
机构：
[1] Graduate School of Pharmaceutical Sciences,Department of Patho
[2] Kyoto University,Functional Bioanalysis
[3] Kyoto University Hospital,undefined
[4] Medical Imaging Project,undefined
[5] Corporate R&D Headquarters,undefined
[6] Canon Inc.,undefined
来源：
Molecular Imaging and Biology | 2016年 / 18卷
关键词：
Molecular MRI; Cancer imaging; Iron oxide nanoparticle; HER2; Single-chain Fv;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：870 / 876
页数：6
相关论文
共 50 条
  • [1] In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody
    Ding, Ning
    Sano, Kohei
    Kanazaki, Kengo
    Ohashi, Manami
    Deguchi, Jun
    Kanada, Yuko
    Ono, Masahiro
    Saji, Hideo
    MOLECULAR IMAGING AND BIOLOGY, 2016, 18 (06) : 870 - 876
  • [2] Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging
    Kanazaki, Kengo
    Sano, Kohei
    Makino, Akira
    Shimizu, Yoichi
    Yamauchi, Fumio
    Ogawa, Satoshi
    Ding, Ning
    Yano, Tetsuya
    Temma, Takashi
    Ono, Masahiro
    Saji, Hideo
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2015, 11 (08) : 2051 - 2060
  • [3] Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer
    Chen, Hongwei
    Wang, Liya
    Yu, Qiqi
    Qian, Weiping
    Tiwari, Diana
    Yi, Hong
    Wang, Andrew Y.
    Huang, Jing
    Yang, Lily
    Mao, Hui
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2013, 8 : 3781 - 3794
  • [4] In vivo breast cancer cell imaging using quantum dot conjugated with anti-HER2 antibody
    Tada, Hiroshi
    Higuchi, Hideo
    Watanabe, Tomonobu M.
    Ohuchi, Noriaki
    FUTURE MEDICAL ENGINEERING BASED ON BIONANOTECHNOLOGY, PROCEEDINGS, 2006, : 515 - +
  • [5] In vivo photoacoustic imaging of breast cancer tumor with HER2-targeted nanodiamonds
    Zhang, Ti
    Cui, Huizhong
    Fang, Chia-Yi
    Jo, Janggun
    Yang, Xinmai
    Chang, Huan-Cheng
    Forrest, M. Laird
    NANOIMAGING AND NANOSPECTROSCOPY, 2013, 8815
  • [6] Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells
    Mu, Qingxin
    Kievit, Forrest M.
    Kant, Rajeev J.
    Lin, Guanyou
    Jeon, Mike
    Zhang, Miqin
    NANOSCALE, 2015, 7 (43) : 18010 - 18014
  • [7] Specific anti-HER2 host immunity conferred by HER2-targeted antibody drug conjugate therapy and checkpoint blockade.
    Qin, You
    Dobson, Hannah E.
    Comer, Frank I.
    Chang, Alfred E.
    Wicha, Max S.
    Li, Qiao
    CANCER RESEARCH, 2021, 81 (13)
  • [8] RBE, in vivo, for a 212Pb-conjugated anti-HER2/neu antibody
    Liatsou, Ioanna
    Josefsson, Anders
    Cortez, Angel
    Hobbs, Robert F.
    Brayton, Cory
    Torgue, Julien
    Sgouros, George
    CANCER RESEARCH, 2020, 80 (16)
  • [9] Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin®) conjugated polyethylemmine
    Chiu, SH
    Ueno, NT
    Lee, RJ
    JOURNAL OF CONTROLLED RELEASE, 2004, 97 (02) : 357 - 369
  • [10] HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb
    Shukla, Rameshwer
    Thomas, Thommey P.
    Peters, Jennifer L.
    Desai, Ankur M.
    Kukowska-Latallo, Jolanta
    Patri, Anil K.
    Kotlyar, Alina
    Baker, James R., Jr.
    BIOCONJUGATE CHEMISTRY, 2006, 17 (05) : 1109 - 1115
12345